The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study
Abstract
In experimental animal models of multiple sclerosis demyelinating antibody responses are directed against the myelin oligodendrocyte glycoprotein (MOG). We have investigated whether a similar antibody response is also present in multiple sclerosis patients. Using the recombinant human extracellular immunoglobulin domain of MOG (MOG-Ig) we have screened the sera and CSFs of 130 multiple sclerosis patients, 32 patients with other inflammatory neurological diseases (OIND), 30 patients with other non-inflammatory neurological diseases (ONND) and 10 patients with rheumatoid arthritis. We report that 38% of multiple sclerosis patients are seropositive for IgG antibodies to MOG-Ig compared with 28% seropositive for anti-myelin basic protein (MBP). In contrast, OIND are characterized by similar frequencies of serum IgG antibody responses to MOG-Ig (53%) and MBP (47%), whereas serum IgG responses to MOG-Ig are rare in ONND (3%) and rheumatoid arthritis (10%). Anti-MBP IgG antibodies, however, are a frequent finding in ONND (23%) and rheumatoid arthritis (60%). Our results provide clear evidence that anti-MOG-Ig antibodies are common in CNS inflammation. However, in OIND these antibody responses are transient, whereas they persist in multiple sclerosis. We demonstrate that the serum anti-MOG-Ig response is already established in early multiple sclerosis (multiple sclerosis-R0; 36%). In later multiple sclerosis stages frequencies and titres are comparable with early multiple sclerosis. In contrast, the frequency of anti-MBP antibodies is low in multiple sclerosis-R0 (12%) and increases during disease progression in relapsing-remitting (32%) and chronic progressive multiple sclerosis (40%), thus suggesting that anti-MBP responses accumulate over time. Finally we provide evidence for intrathecal synthesis of IgG antibodies to MOG-Ig in multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Linington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed · Cited by 708
Self-citationStorch, M. K., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 522
Self-citationMultiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., & Lassmann, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430409 · Cited by 422
Brunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J., & Linington, C. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10930.x · Cited by 409
Self-citationPatterns of oligodendroglia pathology in multiple sclerosis
Ozawa, K., Suchanek, G., Breitschopf, H., Br€ck, W., Budka, H., Jellinger, K., & Lassmann, H. (1994) · Brain · doi:10.1093/brain/117.6.1311 · Cited by 404
Amor, S., Groome, N., Linington, C., Morris, M. M., Dornmair, K., Gardinier, M. V., Matthieu, J. M., & Baker, D. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4349 · Cited by 380
Self-citationLink, H., & Tibbling, G. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517709091498 · Cited by 372
Schluesener, H. J., Sobel, R. A., Linington, C., & Weiner, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4016 · Cited by 371
Self-citationTHE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS
Ludwin, S. K. (2000) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00665-3 · Cited by 329
Kerlero de Rosbo, N., Milo, R., Lees, M. B., Burger, D., Bernard, C. C., & Ben-Nun, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116875 · Cited by 325
A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody
Linnington, C., Webb, M., & Woodhams, P. L. (1984) · Journal of Neuroimmunology · doi:10.1016/0165-5728(84)90064-x · Cited by 321
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
Sun, J., Link, H., Olsson, T., Xiao, B. G., Andersson, G., Ekre, H. P., Linington, C., & Diener, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.5.1490 · Cited by 315
Self-citationAntibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain, C. P., Nguyen, M. H., Letvin, N. L., Pearl, R., Davis, R. L., Adelman, M., Lees, M. B., Linington, C., & Hauser, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118368 · Cited by 314
Self-citationMultiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
Prineas, J. W., & Graham, J. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100205 · Cited by 264
Litzenburger, T., Fässler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H., & Iglesias, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.169 · Cited by 256
Self-citationVesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement
Scolding, N. J., Morgan, B. P., Houston, W. A. J., Linington, C., Campbell, A. K., & Compston, D. A. S. (1989) · Nature · doi:10.1038/339620a0 · Cited by 245
Self-citationMyelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily
Gardinier, M. V., Amiguet, P., Linington, C., & Matthieu, J. ‐. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330123 · Cited by 244
Self-citationBLOOD-BRAIN BARRIER DAMAGE IN ACUTE MULTIPLE SCLEROSIS PLAQUES: AN IMMUNOCYTOLOGICAL STUDY
GAY, D., & ESIRI, M. (1991) · Brain · doi:10.1093/brain/114.1.557 · Cited by 239
Adelmann, M., Wood, J., Benzel, I., Fiori, P., Lassmann, H., Matthieu, J.-M., Gardinier, M. V., Dornmair, K., & Linington, C. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00124-7 · Cited by 232
Self-citationLinington, C., & Lassmann, H. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90031-2 · Cited by 221
Self-citationMCLEAN, B. N., LUXTON, R. W., & THOMPSON, E. J. (1990) · Brain · doi:10.1093/brain/113.5.1269 · Cited by 206
Xiao, B.-G., Linington, C., & Link, H. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90014-x · Cited by 197
Self-citationde Rosbo, N. K., Honegger, P., Lassmann, H., & Matthieu, J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04173.x · Cited by 166
Lebar, R., Lubetzki, C., Vincent, C., Lombrail, P., & Boutry, J. M. (1986) · PubMed Central · Cited by 151
Antimyelin basic protein and antimyelin antibody‐producing cells in multiple sclerosis
Olsson, T. P., Baig, S., jeberg, B. H., & Link, H. (1990) · Annals of Neurology · doi:10.1002/ana.410270207 · Cited by 133
EYLAR, E. H., Kniskern, P. J., & Jackson, J. J. (1974) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(74)32034-4 · Cited by 112
The major myelin protein genes are expressed in the human thymus
Pribyl, T. M., Campagnoni, C. W., Kampf, K., Handley, V., & Campagnoni, A. T. (1996) · Journal of Neuroscience Research · Cited by 102
Myelin antigen reactive T cells in cerebrovascular diseases
WANG, W. Z., Olsson, T. P., Kostulas, V., Höjeberg, B., Ekre, H. P., & Link, H. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb03056.x · Cited by 90
Walsh, M. J., & Murray, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1983 · Cited by 81
Investigation of Myelin/Oligodendrocyte Glycoprotein Membrane Topology
Kroepfl, J. F., Viise, L. R., Charron, A. J., Linington, C., & Gardinier, M. V. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052219.x · Cited by 77
Self-citationBaig, S., Olsson, T. P., YU‐PING, J., Höjeberg, B., Cruz, M. H., & Link, H. (1991) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1991.tb02493.x · Cited by 68
Peripheral Blood Lymphocytes Respond Predominantly to Myelin Oligodendrocyte Glycoprotein
de Rosbo, N. K., Milo, R., Lees, M. B., et al. (1993) · Cited by 52
Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy
Olsson, T. P., Sun, J., Solders, G., Xiao, B., Höjeberg, B., Ekre, H. P., & Link, H. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90165-u · Cited by 48
Antibody-dependent lymphocyte cytotoxicity against basic protein of myelin in multiple sclerosis
Frick, E., & Stickl, H. (1980) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(80)90077-5 · Cited by 29
Mithen, F. A., Agrawal, H. C., EYLAR, E. H., et al. (1982) · Brain Research · doi:10.1016/0006-8993(82)90426-7 · Cited by 19
Mithen, F. A., Agrawal, H. C., Fishman, M. A., et al. (1982) · Brain Research · doi:10.1016/0006-8993(82)90427-9 · Cited by 13
Regulation of fucosyltransferase-VII expression in peripheral lymph node high endothelial venules
(1998) · doi:10.1002/(sici)1521-4141(199810)28:10
Cited by
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy
Lassmann, H., Brück, W., & Lucchinetti, C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01909-2 · Cited by 627
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Reindl, M., & Waters, P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0112-x · Cited by 626
Self-citationBerger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F., & Reindl, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022328 · Cited by 616
Self-citationNew concepts in the immunopathogenesis of multiple sclerosis
Hemmer, B., Archelos, J. J., & Hartung, H.-P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn784 · Cited by 580
Metadata
- Authors
- Reindl, M., Linington, C., Brehm, U., Egg, R., Dilitz, E., Deisenhammer, F., Poewe, W., & Berger, T.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-11
- Volume
- 122
- Issue
- 11
- Pages
- 2047-2056
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2028435653
- Cited by
- 347
- References
- 41
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.